• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Leigh Disease

Leigh Disease - 5 Studies Found

Completed : Safety and Efficacy Study of EPI-743 in Children With Leigh Syndrome
: Leigh Syndrome
: 2012-11-01
:
  • Drug: Placebo
  • Drug: EPI-743 15 mg/kg

Enrolling by invitation : Long-Term Safety and Efficacy Evaluation of EPI-743 in Children With Leigh Syndrome
: Leigh Syndrome
: 2014-08-21
: Drug: EPI-743 EPI-743 is a quinone oxidation product of alpha tocotrienol
Completed : A Dose-escalating Clinical Trial With KH176
:
  • MELAS
  • LHON
  • Leigh Syndrome : 2015-04-19
    :
    • Drug: KH176
    • Drug: placebo

Enrolling by invitation : Tissue Sample Study for Mitochondrial Disorders
:
  • Mitochondrial Disorders
  • Mitochondrial Disease
  • Melas
  • <
    : 2012-08-31
Active, not recruiting : EPI-743 for Mitochondrial Respiratory Chain Diseases
: Mitochondrial Diseases
: 2011-06-07
: Drug: EPI-743 EPI-743 is administered as a dose escalation from 50 mg bid to 100 mg tid
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.